Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Microorganisms|March 28, 2024
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future ProspectsLaura Sneller, Christine Lin, Angie Price, et al.The Journal of the Association of Nurses in AIDS Care : JANAC|March 22, 2016
HIV/HCV Co-infection: Overcoming Barriers to TreatmentChloe Gross, Elizabeth Akoth, Angie Price, et al.Therapeutic Innovation & Regulatory Science|June 20, 2024
Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials DeliverySabah Attar, Angie Price, Collin Hovinga, et al.Hepatology (Baltimore, Md.)|June 15, 2007
Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alphaMitchell L Shiffman, Jennifer Salvatore, Sarah Hubbard, et al.Contemporary Clinical Trials|September 26, 2024
Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processesAngie Price, Hannah Simmons, Emily Gehring, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 1, 2014
Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagusPatrick Yachimski, Sachin Wani, Tonya Givens, et al.Journal of Hepatology|June 8, 2019
A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)Eleanor Wilson, Emily Covert, Jennifer Hoffmann, et al.Annals of Internal Medicine|August 9, 2017
Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical TrialSarah Kattakuzhy, Chloe Gross, Benjamin Emmanuel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2015
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral RegimensEleanor M Wilson, Sarah Kattakuzhy, Sreetha Sidharthan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.Pageof 2